Medication info

Pitavro Tablets 2mg (Pitavastatin Calcium)

Prescription medicationTabletOralExpired
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
Very pale yellowish-red round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201907213 · Approved 2019.10.14

This product's status changed to Expired on 2024.10.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients receiving this medicine, both before and during treatment, must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial
  • non-familial
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL cholesterol
  • Apo-B protein
  • triglycerides
View approved original text

This medication helps to control cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. In particular, it effectively lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels while increasing HDL cholesterol, known as 'good cholesterol.' This drug is used to reduce the risk of cardiovascular diseases by improving blood lipid levels in conjunction with dietary therapy.

How to take

Adult dose

Patients receiving this medicine, both before and during treatment, must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 milligrams daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goals, and patient response. The effect of this medicine is maintained with continued administration.

Precautions

This medication should not be administered to certain patients. Patients with an allergy to any component of this drug, those with liver function issues, severe liver disease, or cholestasis, and those taking cyclosporine should not use it. It is also contraindicated in individuals with myopathy, those who are pregnant or may become pregnant, breastfeeding women, and children. Additionally, patients with lactose intolerance or specific genetic issues should not take this medication. Caution should be exercised when using this drug in patients with renal dysfunction, a history of liver disease, excessive alcohol consumption, and the elderly. Notably, muscle damage or worsening of renal function may occur when combined with certain medications, so close monitoring is required when using these drugs together. During treatment with this drug, side effects such as muscle pain, muscle weakness, abdominal pain, rash, fatigue, and liver function abnormalities may occur, so patients should consult medical professionals immediately if these symptoms arise. Regular liver function tests should be performed, and drug therapy should be discontinued if abnormalities are detected. As this drug is used to treat hypercholesterolemia, it is crucial to confirm the diagnosis of hypercholesterolemia through thorough testing before starting treatment, and dietary and exercise considerations should be taken into account. Blood lipid levels should be regularly monitored during treatment to evaluate therapeutic efficacy. This drug may interact with certain medications, so patients should inform healthcare providers about any other medications they are taking, particularly when combined with cyclosporine, fibrates, niacin, or erythromycin. Elderly patients may experience side effects more readily due to decreased bodily function, so dosage adjustments and caution are necessary. Pregnant or breastfeeding women should not take this medication, and women of childbearing potential should check for pregnancy before starting treatment. Safety and efficacy in children have not been established, so use in this population is not advised. This medication should be stored out of reach of children and kept in its original container to maintain quality.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 83 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • elevated cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal distention
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • fatigue
  • positive antinuclear antibodies
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness
  • nausea
  • thrombocytopenia
  • increased serum creatinine.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in an opaque container that does not allow light in. It is also important to store it at room temperature, between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Very pale yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.